331 related articles for article (PubMed ID: 36439976)
21. A Review of the Recent Development in the Synthesis and Biological Evaluations of Pyrazole Derivatives.
Ebenezer O; Shapi M; Tuszynski JA
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625859
[TBL] [Abstract][Full Text] [Related]
22. Pyrazole Scaffolds: Centrality in Anti-Inflammatory and Antiviral Drug Design.
Karati D; Mahadik KR; Kumar D
Med Chem; 2022; 18(10):1060-1072. PubMed ID: 35410619
[TBL] [Abstract][Full Text] [Related]
23. Biological Significance of Imidazole-based Analogues in New Drug Development.
Chopra PN; Sahu JK
Curr Drug Discov Technol; 2020; 17(5):574-584. PubMed ID: 30894111
[TBL] [Abstract][Full Text] [Related]
24. Pyrazole Paradigms: Unveiling Synthetic Pathways and Unraveling Anti-Cancer Potential.
Kumari P; Agrawal N; Mujwar S
Med Chem; 2024 May; ():. PubMed ID: 38757317
[TBL] [Abstract][Full Text] [Related]
25. Recent Applications of the Multicomponent Synthesis for Bioactive Pyrazole Derivatives.
Becerra D; Abonia R; Castillo JC
Molecules; 2022 Jul; 27(15):. PubMed ID: 35897899
[TBL] [Abstract][Full Text] [Related]
26. A review on antioxidant potential of bioactive heterocycle benzofuran: Natural and synthetic derivatives.
Chand K; Rajeshwari ; Hiremathad A; Singh M; Santos MA; Keri RS
Pharmacol Rep; 2017 Apr; 69(2):281-295. PubMed ID: 28171830
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Outlook of Pyrazole Analogs: A Mini Review.
Ganguly S; Jacob SK
Mini Rev Med Chem; 2017; 17(11):959-983. PubMed ID: 26586126
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and pharmacological activities of azo dye derivatives incorporating heterocyclic scaffolds: a review.
Mezgebe K; Mulugeta E
RSC Adv; 2022 Sep; 12(40):25932-25946. PubMed ID: 36199603
[TBL] [Abstract][Full Text] [Related]
30. A Molecular Insight into Pyrazole Congeners as Antimicrobial, Anticancer, and Antimalarial Agents.
Karati D; Mahadik KR; Trivedi P; Kumar D
Med Chem; 2022; 18(10):1044-1059. PubMed ID: 35240964
[TBL] [Abstract][Full Text] [Related]
31. Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors.
Angeli A; Paoletti N; Supuran CT
Molecules; 2023 Apr; 28(7):. PubMed ID: 37049983
[TBL] [Abstract][Full Text] [Related]
32. An Overview of the Biological Evaluation of Selected Nitrogen-Containing Heterocycle Medicinal Chemistry Compounds.
Ebenezer O; Jordaan MA; Carena G; Bono T; Shapi M; Tuszynski JA
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897691
[TBL] [Abstract][Full Text] [Related]
33. Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents.
Liu JJ; Zhao MY; Zhang X; Zhao X; Zhu HL
Mini Rev Med Chem; 2013 Nov; 13(13):1957-66. PubMed ID: 23937232
[TBL] [Abstract][Full Text] [Related]
34. Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents.
Zhang Y; Wu C; Zhang N; Fan R; Ye Y; Xu J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628906
[TBL] [Abstract][Full Text] [Related]
35. Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016-2022).
Shabir G; Saeed A; Zahid W; Naseer F; Riaz Z; Khalil N; Muneeba ; Albericio F
Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631077
[TBL] [Abstract][Full Text] [Related]
36. Pyrazole scaffold-based derivatives: A glimpse of α-glucosidase inhibitory activity, SAR, and route of synthesis.
Firdaus JU; Siddiqui N; Alam O; Manaithiya A; Chandra K
Arch Pharm (Weinheim); 2023 May; 356(5):e2200421. PubMed ID: 36617511
[TBL] [Abstract][Full Text] [Related]
37. Development of pyrazole derivatives in the management of inflammation.
Turones LC; Martins AN; Moreira LKDS; Fajemiroye JO; Costa EA
Fundam Clin Pharmacol; 2021 Apr; 35(2):217-234. PubMed ID: 33171533
[TBL] [Abstract][Full Text] [Related]
38. Recent advancements in the development of heterocyclic anti-inflammatory agents.
Sharma S; Kumar D; Singh G; Monga V; Kumar B
Eur J Med Chem; 2020 Aug; 200():112438. PubMed ID: 32485533
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and fungicidal activity of novel pyrazole derivatives containing 5-Phenyl-2-Furan.
Ahmed W; Yan X; Hu D; Adnan M; Tang RY; Cui ZN
Bioorg Med Chem; 2019 Oct; 27(19):115048. PubMed ID: 31439387
[TBL] [Abstract][Full Text] [Related]
40. Recent advancement in the discovery and development of COX-2 inhibitors: Insight into biological activities and SAR studies (2008-2019).
Sharma V; Bhatia P; Alam O; Javed Naim M; Nawaz F; Ahmad Sheikh A; Jha M
Bioorg Chem; 2019 Aug; 89():103007. PubMed ID: 31132600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
